Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Acta Neurologica Scandinavica|May 2, 2015
Lacosamide cardiac safety: a thorough QT/QTc trial in healthy volunteersD Kropeit, M Johnson, W Cawello, et al.
European Journal of Clinical Pharmacology|January 1, 1994
Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjectsW Cawello, H Schweer, R Müller, et al.
Klinische Wochenschrift|March 15, 1989
Pharmacokinetics of isosorbide dinitrate, isosorbide-2-nitrate and isosorbide-5-nitrate in renal insufficiency after repeated oral dosageJ Evers, R Bonn, A Boertz, et al.
The Journal of Urology|September 25, 1997
Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunctionW Cawello, H Schweer, B Dietrich, et al.
British Journal of Clinical Pharmacology|September 1, 1995
Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusionW Cawello, A Leonhardt, H Schweer, et al.
Pharmaceutical Research|December 1, 1987
Investigation of the gastrointestinal transit and in vivo drug release of isosorbide-5-nitrate pelletsW Fischer, A Boertz, S S Davis, et al.
Clinical Pharmacology and Therapeutics|July 25, 2008
Thorough QT/QTc study in patients with advanced Parkinson's disease: cardiac safety of rotigotineM Malik, J-O Andreas, K Hnatkova, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Pharmacokinetics of isosorbide-5-nitrate during haemodialysis and peritoneal dialysisJ Evers, R Bonn, A Boertz, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetics of isosorbide-5-nitrate in renal failureJ Evers, B Krakamp, W Klimkait, et al.
European Journal of Clinical Pharmacology|January 1, 1993
Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarinA Van Hecken, R Verbesselt, M Depré, et al.
Pageof 3